Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Coronary Drug-Eluting Stent Sales Volumes Slow as Studies Demonstrate Overutilization: Will Higher Scrutiny Resulting from Obamacare Increase these Pressures?
Coronary Drug-Eluting Stent Sales Volumes Slow as Studies Demonstrate Overutilization: Will Higher Scrutiny Resulting from Obamacare Increase these Pressures?
Coronary Drug-Eluting Stent Sales Volumes Slow as Studies Demonstrate Overutilization: Will Higher Scrutiny Resulting from Obamacare Increase these Pressures?
Submitted by
moderatorj
on August 14, 2012 - 9:45pm
Source:
Yahoo/TheWallStreetTranscript
News Tags:
coronary
drug-eluting
stent
Obamacare
Headline:
Coronary Drug-Eluting Stent Sales Volumes Slow as Studies Demonstrate Overutilization: Will Higher Scrutiny Resulting from Obamacare Increase these Pressures?
Do Not Allow Advertisers to Use My Personal information
